Press

All media inquiries can be directed to info@wuxinextcode.com.

Featured

In Ireland, WuXi NextCODE Embarks on Unprecedented Effort to Enable Precision Medicine at National Scale, with Global Impact

Centerpiece of this effort is the acquisition of Genomics Medicine Ireland (GMI) as WXNC's Irish subsidiary, part of $400m in Ireland precision medicine investments announced today.

See Details

June 11, 2019

WuXi NextCODE Clarifications to Public Letter Sent to Department of Health and Human Services Acting Inspector General Joanne M. Chiedi

WuXi NextCODE ("we" or the "Company"), the emerging global standard platform for genomics, today provided the following clarifications to the public letter (the "Letter") sent by the U.S. Senate Finance Committee Chairman Chuck Grassley and Senator Marco Rubio yesterday to Department of Health and Human Services (HHS) Acting Inspector General (IG) Joanne M. Chiedi requesting oversight on potential payments made to U.S. entities with partnerships to companies with ties to the Chinese government.

March 30, 2019

WuXi NextCODE Launches New State-of-the-art Genetic Analysis Laboratory in U.S. with Illumina’s New TruSight 500™ Assay

WuXi NextCODE, a global genomic data and insights company, is expanding its laboratory footprint into the U.S. with the opening of a state-of-the-art, CLIA-certified and CAP-accredited genetic analysis laboratory in Woburn, Massachusetts. The new laboratory is geographically close to WuXi NextCODE's U.S. office in Cambridge, Massachusetts.

November 27, 2018

WuXi NextCODE Completes $200 Million Series C Financing

Leading global sovereign and technology investors from Ireland, Singapore, US and China back its data strategy to expand the reach and power of the leading global platform in genomics. Major investments in Ireland aim to create the world's premier genomic and medical dataset, uniquely powered to accelerate drug discovery and deliver meaningful benefits of precision medicine to global patients.

September 24, 2018

WuXi NextCODE named in Fast Company’s Top 10 Most Innovative Companies in Biotech 2018

September 19, 2018

WuXi NextCODE Unveils Genomics Partnership with Google Cloud

April 26, 2018

Introducing an Internet of DNA for Solving Rare Disease

At the World Orphan Drug Congress on April 26, WuXi NextCODE presents novel global strategy to accelerate diagnosis and better treatments to improve the lives of patients worldwide.

April 15, 2018

GRAIL and Amgen Veteran Richard Williams to Lead Cancer Genomics Business

At AACR, Williams and colleagues will showcase the company's portfolio of cutting edge capabilities for using genomic data to optimize and advance cancer therapies

March 12, 2018

WuXi NextCODE Announces Executive Leadership Transition

January 18, 2018

WuXi NextCODE Appoints Accomplished Life Sciences Senior Executive Louis Yuan as China General Manager

January 9, 2018

AI Advances Precision Therapy for Rare Genetic Disorders of Obesity

November 9, 2017